Skip to content
Opening soonHORIZON-CL3-2027-01-FCT-05REAOne-off

Effective and evidence-based responses to the increased availability and use of synthetic drugs and stimulants in Europe

An evidence-based approach to synthetic drugs and stimulants.

Horizon Europe Innovation Action (lump sum, around €4 million per project) for evidence-based prevention, treatment, harm reduction and investigation relating to synthetic drugs and stimulants, with at least 3 police authorities and 2 civil society organisations.

Opening soon
168
days until opening
Opens on 5 May 2027
HORIZON-CL3-2027-01-FCT-05
View all deadlines
Beta

This grant database is in beta

Until the official launch on 1 January 2027 we are making the final improvements. Our editors check every scheme, but details may still be incomplete or out of date. Check the official publication before you apply.

In brief

What is Effective and evidence-based responses to the increased availability and use of synthetic drugs and stimulants in Europe?

Who
Legal entities such as companies of any size, research organisations, public authorities, foundations and associations, in a consortium of at least three independent entities from three different EU Member States or Associated Countries, including as beneficiaries at least 3 police authorities and 2 civil society organisations from at least 3 different countries.
3. Other Eligible Conditions; General Annex B
What for
An effective, evidence-based response to the increasing availability and use of synthetic drugs and stimulants in Europe.
Expected Outcome en Scope
What you get
A lump sum covering up to 70% of the costs. The indicative budget for this topic is €8 million.
Budget overview; 6. Legal and financial set-up of the grants; General Annex G
What you need to do
Submit a proposal via the Funding & Tenders Portal by 4 November 2027 at 17:00 (Brussels time), with application form Part A and Part B; the call opens on 5 May 2027. Independent experts evaluate and rank the proposals; results follow around 5 months after the deadline.
Budget overview; General Annex F

Built from the details on this page, with nothing added by us.

Consortium
5+ partners
Purpose & impact

Why does this scheme exist?

To provide Europe with an effective, evidence-based response to the increasing availability and use of synthetic drugs and stimulants.

01
Stronger knowledge base
The knowledge base for effective prevention, treatment and harm reduction relating to synthetic drugs and stimulants in Europe is improved.
02
Equipped practitioners
Police, civil society organisations and NGOs gain skills, tools and technology to reduce violence and crime related to the use of and trade in these substances and to combat drug trafficking.
03
Insight into external drivers
Security practitioners and policymakers better understand how societal, technological, legal, economic and ethical developments affect the availability and use of synthetic drugs and drug markets.
Description

About the scheme

Compiled from passages of the scheme's official publication, with nothing added by us.

Project results are expected to contribute to all of the following expected outcomes: - Evidence base is improved for effective prevention, treatment and harm reduction of synthetic drugs and stimulants in Europe; - Relevant European security practitioners, notably Police Authorities, Civil Society Organisations and Non-Governmental Organisations, are equipped with skills, tools and technology aimed at reducing the violence and offences associated with use and marketing of these substances, as well as at combatting drug trafficking from its origin to destination (i.e., through the entire supply chain); - Increased understanding of relevant European security practitioners and policymakers regarding the influence of external drivers of change of societal, technological, legal, economic and ethical nature to the availability and use of different types of synthetic drugs and drug markets.

Am I eligible?

Conditions

Quoted verbatim from the scheme, with the article that sets each condition.

01
Unless otherwise provided for in the specific call/topic conditions, only legal entities forming a consortium are eligible to participate in actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows: – at least one independent legal entity established in a Member State; and – at least two other independent legal entities, each established in different Member States or Associated Countries.
02
This topic requires the active involvement, as beneficiaries, of at least 3 Police Authorities[[In the context of this Destination, ‘Police Authorities’ means public authorities explicitly designated by national law, or other entities legally mandated by the competent national authority, for the prevention, detection and/or investigation of terrorist offences or other criminal offences, specifically excluding police academies, forensic institutes, training facilities as well as border and customs authorities.]] and at least 2 Civil Society Organisations (or Non-Governmental Organisations) from at least 3 different EU Member States or Associated Countries. For these participants, applicants must fill in the table “Information about security practitioners” in the application form with all the requested information, following the template provided in the submission IT tool.
03
If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).
04
Legal entities established in China are not eligible to participate in both Research and Innovation Actions (RIAs) and Innovation Actions (IAs) falling under this destination.
All sizes
Micro< 10 FTE
Small< 50 FTE
Medium< 250 FTE
Large≥ 250 FTE
Themes
Veiligheid, defensie en weerbaarheidOnderzoek, ontwikkeling en innovatieOpenbare orde en criminaliteit
Project phase
DevelopmentDemonstration
Funding

What do you get?

70% of your eligible project costs.

Note on the maximum
No binding maximum; the Commission considers an EU contribution of around €4.0 million per project appropriate (lump sum). Innovation Action: 70% funding, non-profit organisations up to 100%.
Total scheme budget
€8m · Indicative topic budget, 2 projects expected to be funded.
Budget status
Not published by the source
The sources do not say how much budget is left (checked 18 November 2026).
No double funding: an action may receive only one grant from the EU budget (except EU Synergy grants), and the same costs may never be declared under two different EU actions (General Annex G).
Type
Direct grant (non-repayable)
Calendar

Deadlines & cycles

5
MAY
HORIZON-CL3-2027-01-FCT-05 opens 5 May 2027
Budget overview
Cycle: Evaluation results around 5 months after the deadline; signature of the grant agreement around 8 months after the deadline (General Annex F). General Annex F, Indicative timetable for evaluation and for signature of the grant agreement
Application

How do you apply?

Pre-registration
Required, before the full application
Required attachments
  • Application form Part A: administrative data of the participants and summarised budget (to be completed online)
  • Application form Part B: technical description of the project (PDF, maximum 45 pages for a lump sum IA)
  • Detailed budget table (HE LS) as the basis for the lump sum
  • Table 'Information about security practitioners' in the application form, with the details of the participating security practitioners
Procedure
Apply via the Funding & Tenders Portal with an EU Login and a PIC number; single-stage; deadline 17:00 Brussels time; managed by the European Research Executive Agency (REA).
Eligible costs

What can the money be spent on?

Personnel costs
Not eligible
Materials
Not eligible
Subcontracting
Not eligible
Equipment
Not eligible
Land
Not eligible
Buildings
Not eligible
Overheads
Not eligible
Travel costs
Not eligible
Other costs
Lump sum: fixed contribution per work package, no cost reporting. Funding rate 70%; non-profit organisations (such as police services and NGOs) receive up to 100%.
Downloads

Files & forms

Changes

What has changed?

10 November 2026scheme · version 5

Subtitle
Subtitle: ChangedShow
Before

Onderbouwde aanpak van synthetische drugs en stimulantia.

Now

An evidence-based approach to synthetic drugs and stimulants.

Description
Description: ChangedShow
Before

Projecten versterken de kennisbasis voor preventie, behandeling en schadebeperking bij synthetische drugs en stimulantia zoals cocaïne en crack, en rusten politie en maatschappelijke organisaties uit met vaardigheden, tools en technologie tegen drugsgerelateerd geweld en drugshandel in de hele keten. Ook de invloed van geopolitieke, juridische en maatschappelijke ontwikkelingen op drugsmarkten wordt onderzocht, in samenwerking met Europol en het EU-drugsagentschap.

Now

Projects strengthen the knowledge base for prevention, treatment and harm reduction relating to synthetic drugs and stimulants such as cocaine and crack, and equip police and civil society organisations with skills, tools and technology to tackle drug-related violence and drug trafficking along the entire chain. The influence of geopolitical, legal and societal developments on drug markets is also examined, in cooperation with Europol and the EU Drugs Agency.

Short description
Short description: ChangedShow
Before

Horizon Europe-innovatieactie (lump sum, circa € 4 mln per project) voor onderbouwde preventie, behandeling, schadebeperking en opsporing rond synthetische drugs en stimulantia, met minimaal 3 politieautoriteiten en 2 maatschappelijke organisaties.

Now

Horizon Europe Innovation Action (lump sum, around €4 million per project) for evidence-based prevention, treatment, harm reduction and investigation relating to synthetic drugs and stimulants, with at least 3 police authorities and 2 civil society organisations.

Cycle
Cycle: ChangedShow
Before

Uitslag van de evaluatie rond 5 maanden na de deadline; ondertekening van de subsidieovereenkomst rond 8 maanden na de deadline (General Annex F).

Now

Evaluation results around 5 months after the deadline; signature of the grant agreement around 8 months after the deadline (General Annex F).

Note on the total budget
Note on the total budget: ChangedShow
Before

Indicatief topicbudget, naar verwachting 2 projecten.

Now

Indicative topic budget, 2 projects expected to be funded.

Note on the maximum
Note on the maximum: ChangedShow
Before

Geen bindend maximum; de Commissie acht circa € 4,0 mln EU-bijdrage per project passend (lump sum). Innovatieactie: 70% financiering, non-profitorganisaties tot 100%.

Now

No binding maximum; the Commission considers an EU contribution of around €4.0 million per project appropriate (lump sum). Innovation Action: 70% funding, non-profit organisations up to 100%.

Cumulation
Cumulation: ChangedShow
Before

Geen dubbele financiering: een actie kan maar één subsidie uit de EU-begroting krijgen (behalve EU Synergy grants) en dezelfde kosten mogen nooit bij twee verschillende EU-acties worden gedeclareerd (General Annex G).

Now

No double funding: an action may receive only one grant from the EU budget (except EU Synergy grants), and the same costs may never be declared under two different EU actions (General Annex G).

Search engine title
Aanpak synthetische drugs en stimulantia (Horizon CL3) becomes Tackling synthetic drugs and stimulants (Horizon CL3)
Search engine description
Search engine description: ChangedShow
Before

Horizon Europe-innovatieactie (circa € 4 mln per project) voor preventie, schadebeperking en bestrijding van synthetische drugs en drugshandel.

Now

Horizon Europe Innovation Action (around €4 million per project) for prevention, harm reduction and combating synthetic drugs and drug trafficking.

Keywords
Cluster 3 Civil Security for Society, drugshandel, Horizon Europe, HORIZON-CL3-2027-01-FCT-05, schadebeperking, synthetische drugs becomes Cluster 3 Civil Security for Society, drug trafficking, harm reduction, Horizon Europe, HORIZON-CL3-2027-01-FCT-05, synthetic drugs
Language
Dutch (Netherlands) becomes British English
Required attachments
Aanvraagformulier deel A: administratieve gegevens van de deelnemers en samengevatte begroting (online in te vullen); Aanvraagformulier deel B: technische beschrijving van het project (pdf, maximaal 45 pagina's voor een lump-sum IA); Gedetailleerde begrotingstabel (HE LS) als basis voor de lump sum; Tabel 'Information about security practitioners' in het aanvraagformulier, met de gegevens van de deelnemende veiligheidspraktijkmensen becomes Application form Part A: administrative data of the participants and summarised budget (to be completed online); Application form Part B: technical description of the project (PDF, maximum 45 pages for a lump sum IA); Detailed budget table (HE LS) as the basis for the lump sum; Table 'Information about security practitioners' in the application form, with the details of the participating security practitioners
Procedure
Procedure: ChangedShow
Before

Aanvragen via het Funding & Tenders Portal met een EU Login en een PIC-nummer; single-stage; deadline 17:00 uur Brusselse tijd; beheerd door European Research Executive Agency (REA).

Now

Apply via the Funding & Tenders Portal with an EU Login and a PIC number; single-stage; deadline 17:00 Brussels time; managed by the European Research Executive Agency (REA).

Notes per cost type
Notes per cost type: ChangedShow
Before

Other costs: Lump sum: vaste bijdrage per werkpakket, geen kostenverantwoording. Financieringspercentage 70%; non-profitorganisaties (zoals politiediensten en ngo's) ontvangen tot 100%.

Now

Other costs: Lump sum: fixed contribution per work package, no cost reporting. Funding rate 70%; non-profit organisations (such as police services and NGOs) receive up to 100%.

Why this scheme
Why this scheme: ChangedShow
Before

Europa een effectieve, onderbouwde aanpak bieden van de groeiende beschikbaarheid en het gebruik van synthetische drugs en stimulantia.

Now

To provide Europe with an effective, evidence-based response to the increasing availability and use of synthetic drugs and stimulants.

In brief
In brief: ChangedShow
Before

Who: Juridische entiteiten zoals bedrijven van elke omvang, onderzoeksinstellingen, overheden, stichtingen en verenigingen, in een consortium van ten minste drie onafhankelijke partijen uit drie verschillende EU-lidstaten of geassocieerde landen, met als begunstigden ten minste 3 politieautoriteiten en 2 maatschappelijke organisaties uit ten minste 3 verschillende landen.

What for: Een effectieve, onderbouwde aanpak van de groeiende beschikbaarheid en het gebruik van synthetische drugs en stimulantia in Europa.

What you get: Een lump sum die maximaal 70% van de kosten dekt. Het indicatieve budget voor dit topic is € 8 miljoen.

What you need to do: Dien uiterlijk 4 november 2027 om 17:00 uur (Brusselse tijd) een voorstel in via het Funding & Tenders Portal, met aanvraagformulier deel A en B; de call opent op 5 mei 2027. Onafhankelijke experts beoordelen en rangschikken de voorstellen; de uitslag volgt rond 5 maanden na de deadline.

Now

Who: Legal entities such as companies of any size, research organisations, public authorities, foundations and associations, in a consortium of at least three independent entities from three different EU Member States or Associated Countries, including as beneficiaries at least 3 police authorities and 2 civil society organisations from at least 3 different countries.

What for: An effective, evidence-based response to the increasing availability and use of synthetic drugs and stimulants in Europe.

What you get: A lump sum covering up to 70% of the costs. The indicative budget for this topic is €8 million.

What you need to do: Submit a proposal via the Funding & Tenders Portal by 4 November 2027 at 17:00 (Brussels time), with application form Part A and Part B; the call opens on 5 May 2027. Independent experts evaluate and rank the proposals; results follow around 5 months after the deadline.

Goals
Goals: 3 removed, 3 newShow
Removed

Sterkere kennisbasis De kennisbasis voor effectieve preventie, behandeling en schadebeperking bij synthetische drugs en stimulantia in Europa verbetert.

Toegeruste praktijkmensen Politie, maatschappelijke organisaties en ngo's krijgen vaardigheden, instrumenten en technologie om geweld en delicten rond het gebruik van en de handel in deze middelen terug te dringen en drugshandel te bestrijden.

Inzicht in externe drijfveren Veiligheidspraktijkmensen en beleidsmakers begrijpen beter hoe maatschappelijke, technologische, juridische, economische en ethische ontwikkelingen de beschikbaarheid en het gebruik van synthetische drugs en de drugsmarkten beïnvloeden.

New

Stronger knowledge base The knowledge base for effective prevention, treatment and harm reduction relating to synthetic drugs and stimulants in Europe is improved.

Equipped practitioners Police, civil society organisations and NGOs gain skills, tools and technology to reduce violence and crime related to the use of and trade in these substances and to combat drug trafficking.

Insight into external drivers Security practitioners and policymakers better understand how societal, technological, legal, economic and ethical developments affect the availability and use of synthetic drugs and drug markets.

Show 4 earlier versions

19 October 2026scheme · version 4

Conditions
Conditions: 3 removed, 4 newShow
Removed

Consortium van minimaal 3 partijen Drie onafhankelijke juridische entiteiten uit drie verschillende EU-lidstaten of geassocieerde landen, waarvan minimaal één uit een lidstaat (General Annex B).

Minimaal 3 politieautoriteiten en 2 maatschappelijke organisaties Actieve deelname als begunstigde van minimaal 3 Police Authorities en minimaal 2 maatschappelijke organisaties of ngo's uit minimaal 3 verschillende EU-lidstaten of geassocieerde landen; de tabel 'Information about security practitioners' invullen. Police Authorities: bij nationale wet aangewezen of wettelijk gemandateerde instanties voor preventie, opsporing of onderzoek van strafbare feiten, met uitzondering van politieacademies, forensische instituten, opleidingsinstellingen en grens- en douaneautoriteiten.

Geen deelname van Chinese entiteiten In China gevestigde juridische entiteiten mogen niet deelnemen aan onderzoeks- en innovatieacties onder deze destination (General Annex B).

New

Unless otherwise provided for in the specific call/topic conditions, only legal entities forming a consortium are eligible to participate in actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows: – at least one independent legal entity established in a Member State; and – at least two other independent legal entities, each established in different Member States or Associated Countries.

This topic requires the active involvement, as beneficiaries, of at least 3 Police Authorities[[In the context of this Destination, ‘Police Authorities’ means public authorities explicitly designated by national law, or other entities legally mandated by the competent national authority, for the prevention, detection and/or investigation of terrorist offences or other criminal offences, specifically excluding police academies, forensic institutes, training facilities as well as border and customs authorities.]] and at least 2 Civil Society Organisations (or Non-Governmental Organisations) from at least 3 different EU Member States or Associated Countries. For these participants, applicants must fill in the table “Information about security practitioners” in the application form with all the requested information, following the template provided in the submission IT tool.

If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).

Legal entities established in China are not eligible to participate in both Research and Innovation Actions (RIAs) and Innovation Actions (IAs) falling under this destination.

In brief
In brief: AddedShow
Now

Who: Juridische entiteiten zoals bedrijven van elke omvang, onderzoeksinstellingen, overheden, stichtingen en verenigingen, in een consortium van ten minste drie onafhankelijke partijen uit drie verschillende EU-lidstaten of geassocieerde landen, met als begunstigden ten minste 3 politieautoriteiten en 2 maatschappelijke organisaties uit ten minste 3 verschillende landen.

What for: Een effectieve, onderbouwde aanpak van de groeiende beschikbaarheid en het gebruik van synthetische drugs en stimulantia in Europa.

What you get: Een lump sum die maximaal 70% van de kosten dekt. Het indicatieve budget voor dit topic is € 8 miljoen.

What you need to do: Dien uiterlijk 4 november 2027 om 17:00 uur (Brusselse tijd) een voorstel in via het Funding & Tenders Portal, met aanvraagformulier deel A en B; de call opent op 5 mei 2027. Onafhankelijke experts beoordelen en rangschikken de voorstellen; de uitslag volgt rond 5 maanden na de deadline.

18 October 2026scheme · version 3

About the scheme
About the scheme: AddedShow
Now

Project results are expected to contribute to all of the following expected outcomes: - Evidence base is improved for effective prevention, treatment and harm reduction of synthetic drugs and stimulants in Europe; - Relevant European security practitioners, notably Police Authorities, Civil Society Organisations and Non-Governmental Organisations, are equipped with skills, tools and technology aimed at reducing the violence and offences associated with use and marketing of these substances, as well as at combatting drug trafficking from its origin to destination (i.e., through the entire supply chain); - Increased understanding of relevant European security practitioners and policymakers regarding the influence of external drivers of change of societal, technological, legal, economic and ethical nature to the availability and use of different types of synthetic drugs and drug markets.

16 October 2026scheme · version 2

Cycle
Cycle: AddedShow
Now

Uitslag van de evaluatie rond 5 maanden na de deadline; ondertekening van de subsidieovereenkomst rond 8 maanden na de deadline (General Annex F).

Cumulation
Cumulation: AddedShow
Now

Geen dubbele financiering: een actie kan maar één subsidie uit de EU-begroting krijgen (behalve EU Synergy grants) en dezelfde kosten mogen nooit bij twee verschillende EU-acties worden gedeclareerd (General Annex G).

Keywords
Added: Cluster 3 Civil Security for Society, drugshandel, Horizon Europe, HORIZON-CL3-2027-01-FCT-05, schadebeperking, synthetische drugs
Required attachments
Added: Aanvraagformulier deel A: administratieve gegevens van de deelnemers en samengevatte begroting (online in te vullen); Aanvraagformulier deel B: technische beschrijving van het project (pdf, maximaal 45 pagina's voor een lump-sum IA); Gedetailleerde begrotingstabel (HE LS) als basis voor de lump sum; Tabel 'Information about security practitioners' in het aanvraagformulier, met de gegevens van de deelnemende veiligheidspraktijkmensen
Goals
Goals: 3 newShow
New

Sterkere kennisbasis De kennisbasis voor effectieve preventie, behandeling en schadebeperking bij synthetische drugs en stimulantia in Europa verbetert.

Toegeruste praktijkmensen Politie, maatschappelijke organisaties en ngo's krijgen vaardigheden, instrumenten en technologie om geweld en delicten rond het gebruik van en de handel in deze middelen terug te dringen en drugshandel te bestrijden.

Inzicht in externe drijfveren Veiligheidspraktijkmensen en beleidsmakers begrijpen beter hoe maatschappelijke, technologische, juridische, economische en ethische ontwikkelingen de beschikbaarheid en het gebruik van synthetische drugs en de drugsmarkten beïnvloeden.

7 October 2026scheme · version 1 · first publication

Source

Contact & source

Funding body
European Research Executive Agency
Last verified
14 November 2026 by the Twin editors
Start your application

Start your HORIZON-CL3-2027-01-FCT-05 application
in Twin.

Twin helps you write your application, based on the scheme and your own project documents. You stay in control of every text.